Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2013 (2013), Article ID 437134, 14 pages
http://dx.doi.org/10.1155/2013/437134
Research Article

Synthesis and In Vitro Antitumor Activity of Two Mixed-Ligand Oxovanadium(IV) Complexes of Schiff Base and Phenanthroline

1Department of Biology, School of Basic Courses, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China
2Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, Guangdong 510006, China
3Chemistry Department, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China

Received 27 October 2012; Accepted 19 December 2012

Academic Editor: Takao Yagi

Copyright © 2013 Yongli Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. G. Ran, L. Y. Wang, D. R. Cao, Y. C. Lin, and J. Hao, “Synthesis, characterization and in vitro biological activity of cobalt(II), copper(II) and zinc(II) Schiff base complexes derived from salicylaldehyde and D,L-selenomethionine,” Applied Organometallic Chemistry, vol. 25, no. 1, pp. 9–15, 2011. View at Publisher · View at Google Scholar
  2. P. K. Sasmal, A. K. Patra, M. Nethaji, and A. R. Chakravarty, “DNA cleavage by new oxovanadium(IV) complexes of N-salicylidene α-amino acids and phenanthroline bases in the photodynamic therapy window,” Inorganic Chemistry, vol. 46, no. 26, pp. 11112–11121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Vanco, O. Svajlenova, E. Racianska, J. Muselik, and J. Valentova, “Antiradical activity of different copper(II) Schiff base complexes and their effect on alloxan-induced diabetes,” Journal of Trace Elements in Medicine and Biology, vol. 18, no. 2, pp. 155–162, 2004. View at Publisher · View at Google Scholar
  4. J. A. Obaleye, J. F. Adediji, and M. A. Adebayo, “Synthesis and biological activities on metal complexes of 2,5-diamino-1,3,4-thiadiazole derived from semicarbazide hydrochloride,” Molecules, vol. 16, no. 7, pp. 5861–5874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Tai, X. Yin, Q. Chen, and M. Tan, “Synthesis of some transition metal complexes of a novel Schiff base ligand derived from 2,2′-bis(p-methoxyphenylamine) and salicylicaldehyde,” Molecules, vol. 8, no. 5, pp. 439–443, 2003. View at Google Scholar · View at Scopus
  6. P. Noblía, E. J. Baran, L. Otero et al., “New vanadium(V) complexes with salicylaldehyde semicarbazone derivatives: synthesis, characterization, and in vitro insulin-mimetic activity—crystal structure of [VvO2(salicylaldehyde semicarbazone)],” European Journal of Inorganic Chemistry, vol. 2004, no. 2, pp. 322–328, 2004. View at Publisher · View at Google Scholar
  7. P. Pattanayak, J. L. Pratihar, D. Patra et al., “Synthesis, structure and reactivity of azosalophen complexes of vanadium(IV): studies on cytotoxic properties,” Dalton Transactions, no. 31, pp. 6220–6230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Messerschmidt and R. Wever, “X-ray structure of a vanadium-containing enzyme: chloroperoxidase from the fungus Curvularia inaequalis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 1, pp. 392–399, 1996. View at Publisher · View at Google Scholar
  9. D. C. Crans and A. S. Tracey, “The chemistry of vanadium in aqueous and nonaqueous solution,” ACS Symposium Series, vol. 711, pp. 2–29, 1998. View at Google Scholar · View at Scopus
  10. R. Liasko, T. A. Kabanos, S. Karkabounas et al., “Beneficial effects of a vanadium complex with cysteine, administered at low doses on benzo(α) pyrene-induced leiomyosarcomas in wistar rats,” Anticancer Research, vol. 18, no. 5A, pp. 3609–3613, 1998. View at Google Scholar · View at Scopus
  11. P. Prasad, P. K. Sasmal, R. Majumdar, R. R. Dighe, and A. R. Chakravarty, “Photocytotoxicity and near-IR light DNA cleavage activity of oxovanadium(IV) Schiff base complexes having phenanthroline bases,” Inorganica Chimica Acta, vol. 363, no. 12, pp. 2743–2751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. K. Sasmal, S. Saha, R. Majumdar, R. R. Dighe, and A. R. Chakravarty, “Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity,” Inorganic Chemistry, vol. 49, no. 3, pp. 849–859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. Holder, “Inorganic pharmaceuticals,” Annual Reports on the Progress of Chemistry A, vol. 107, pp. 359–378, 2011. View at Publisher · View at Google Scholar
  14. Y. Sun, L. E. Joyce, N. M. Dickson, and C. Turro, “DNA photocleavage by an osmium(ii) complex in the PDT window,” Chemical Communications, vol. 46, no. 36, pp. 6759–6761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. P. Dash, S. Pasayat, S. H. R. Dash, S. Das, R. J. Butcher, and R. Dinda, “Oxovanadium(V) complexes incorporating tridentate aroylhydrazoneoximes: synthesis, characterizations and antibacterial activity,” Polyhedron, vol. 31, no. 1, pp. 524–529, 2012. View at Publisher · View at Google Scholar
  16. S. A. Patil, V. H. Naik, A. D. Kulkarni, U. Kamble, G. B. Bagihalli, and P. S. Badami, “DNA cleavage, in vitro antimicrobial and electrochemical studies of Co(II), Ni(II), and Cu(II) complexes with m-substituted thiosemicarbazide Schiff bases,” Journal of Coordination Chemistry, vol. 63, no. 4, pp. 688–699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. O. S. Frankfurt and A. Krishan, “Apoptosis-based drug screening and detection of selective toxicity to cancer cells,” Anti-Cancer Drugs, vol. 14, no. 7, pp. 555–561, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. H. L. Xu, X. F. Yu, S. C. Qu et al., “Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway,” European Journal of Pharmacology, vol. 645, no. 1–3, pp. 14–22, 2010. View at Publisher · View at Google Scholar
  19. J.-Z. Lu, Y.-F. Du, H.-W. Guo, J. Jiang, X.-D. Zeng, and L.-Q. Zang, “Two oxovanadium complexes incorporating thiosemicarbazones: synthesis, characterization, and DNA-binding studies,” Journal of Coordination Chemistry, vol. 64, no. 7, pp. 1229–1239, 2011. View at Publisher · View at Google Scholar
  20. Y. F. Du, J. Z. Lu, H. W. Guo, and J. Jiang, “DNA binding and photocleavage properties of two mixed-ligand oxovanadium complexes,” Transition Metal Chemistry, vol. 35, pp. 859–864, 2010. View at Google Scholar
  21. J. Z. Lu, X.D. Zeng, H. W. Guo et al., “Synthesis and characterization of unsymmetrical oxidovanadium complexes: DNA-binding, cleavage studies and antitumor activities,” Journal of Inorganic Biochemistry, vol. 112, pp. 39–48, 2012. View at Publisher · View at Google Scholar
  22. I. Kostova, “Titanium and vanadium complexes as anticancer agents,” Anti-Cancer Agents in Medicinal Chemistry, vol. 9, no. 8, pp. 827–842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. K. S. Hazari, J. Kopf, D. Palit, S. Rakshit, and D. Rehder, “Oxidovanadium(IV) complexes containing ligands derived from dithiocarbazates—models for the interaction of VO2+ with thiofunctional ligands,” Inorganica Chimica Acta, vol. 362, no. 4, pp. 1343–1347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Khera, A. K. Sharma, and N. K. Kaushik, “Bis(indenyl)titanium(IV) and zirconium(IV) complexes of monofunctional bidentate salicylidimines,” Polyhedron, vol. 2, no. 11, pp. 1177–1180, 1983. View at Google Scholar · View at Scopus
  25. M. Tümer, H. Köksal, S. Serin, and M. DõgÆrak, “Antimicrobial activity studies of mononuclear and binuclear mixed-ligand copper(II) complexes derived from Schiff base ligands and 1,10-phenanthroline,” Transition Metal Chemistry, vol. 24, no. 1, pp. 13–17, 1998. View at Publisher · View at Google Scholar
  26. M. Tümer, C. Çelik, H. S. K. ksal, and S. Serin, “Transition metal complexes of bidentate Schiff base ligands,” Transition Metal Chemistry, vol. 24, no. 5, pp. 525–532, 1999. View at Publisher · View at Google Scholar
  27. S. K. Dutta, S. B. Kumar, S. Bhattacharyya, E. R. T. Tiekink, and M. Chaudhury, “Intramolecular electron transfer in (BzImH)[(LOV)2O] (H2L = S-methyl 3-((2-Hydroxyphenyl)methyl)dithiocarbazate): a novel μ-Oxo dinuclear oxovanadium(IV/V) compound with a trapped-valence (V2O3)3+ core,” Inorganic Chemistry, vol. 36, no. 22, p. 4954, 1997. View at Publisher · View at Google Scholar
  28. A. A. Nejo, G. A. Kolawole, A. R. Opoku, J. Wolowska, and P. O'Brien, “Synthesis, characterization and preliminary insulin-enhancing studies of symmetrical tetradentate Schiff base complexes of oxovanadium(IV),” Inorganica Chimica Acta, vol. 362, no. 11, pp. 3993–4001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. L. Farmer and F. L. Urbach, “Stereochemistry and electronic structure of oxovanadium(IV) chelates with tetradentate Schiff base ligands derived from 1,3-diamines,” Inorganic Chemistry, vol. 13, no. 3, pp. 587–592, 1974. View at Publisher · View at Google Scholar
  30. V. B. Arion, V. C. Kravtsov, R. Goddard et al., “Oxovanadium(IV) and oxovanadium(IV)-barium(II) complexes with heterotopic macrocyclic ligands based on isothiosemicarbazide,” Inorganica Chimica Acta, vol. 317, no. 1-2, pp. 33–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. X. G. Ran, L. Y. Wang, D. R. Cao, Y. C. Lin, and J. Hao, “Synthesis, characterization and in vitro biological activity of cobalt(II), copper(II) and zinc(II) Schiff base complexes derived from salicylaldehyde and D,L-selenomethionine,” Applied Organometallic Chemistry, vol. 25, no. 1, pp. 9–13, 2011. View at Publisher · View at Google Scholar
  32. B. Banik, P. K. Sasmal, S. Roy, R. Majumdar, R. R. Dighe, and A. R. Chakravarty, “Terpyridine oxovanadium(IV) complexes of phenanthroline bases for cellular imaging and photocytotoxicity in HeLa cells,” European Journal of Inorganic Chemistry, no. 9, pp. 1425–1435, 2011. View at Publisher · View at Google Scholar
  33. R. W. Johnstone, A. A. Ruefli, and S. W. Lowe, “Apoptosis: a link between cancer genetics and chemotherapy,” Cell, vol. 108, no. 2, pp. 153–164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Hu and J. J. Kavanagh, “Anticancer therapy targeting the apoptotic pathway,” The Lancet Oncology, vol. 4, no. 12, pp. 721–729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. J. D. Ly, D. R. Grubb, and A. Lawen, “The mitochondrial membrane potential (ΔΨ m) in apoptosis; an update,” Apoptosis, vol. 8, no. 2, pp. 115–128, 2003. View at Google Scholar · View at Scopus
  36. S. H. Kaufmann and M. O. Hengartner, “Programmed cell death: alive and well in the new millennium,” Trends in Cell Biology, vol. 11, no. 12, pp. 526–534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. C. B. Thompson, “Apoptosis in the pathogenesis and treatment of disease,” Science, vol. 267, no. 5203, pp. 1456–1462, 1995. View at Google Scholar · View at Scopus
  38. S. J. Martin and D. R. Green, “Apoptosis and cancer: the failure of controls on cell death and cell survival,” Critical Reviews in Oncology/Hematology, vol. 18, no. 2, pp. 137–153, 1995. View at Publisher · View at Google Scholar
  39. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger, “A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V,” Journal of Immunological Methods, vol. 184, no. 1, pp. 39–51, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. J. Liu and C. H. Zeng, “Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity,” European Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 3087–3095, 2010. View at Publisher · View at Google Scholar
  41. G. Klopman, “Chemical reactivity and the concept of charge- and frontier-controlled reactions,” Journal of the American Chemical Society, vol. 90, no. 2, pp. 223–229, 1968. View at Publisher · View at Google Scholar
  42. A. Klein, P. Holko, J. Ligeza, and A. M. Kordowiak, “Sodium orthovanadate affects growth of some human epithelial cancer cells (A549, HTB44, DU145),” Folia Biologica, vol. 56, no. 3-4, pp. 115–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. O'Connor, A. Kellett, M. McCann et al., “Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines,” Journal of Medicinal Chemistry, vol. 55, no. 5, pp. 1957–1968, 2012. View at Publisher · View at Google Scholar
  44. R. Kim, “Recent advances in understanding the cell death pathways activated by anticancer therapy,” Cancer, vol. 103, no. 8, pp. 1551–1558, 2005. View at Publisher · View at Google Scholar
  45. R. S. Ray, B. Rana, B. Swami, V. Venu, and M. Chatterjee, “Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line,” Chemico-Biological Interactions, vol. 163, no. 3, pp. 239–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Benítez, L. Becco, I. Correia et al., “Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements,” Journal of Inorganic Biochemistry, vol. 105, no. 2, pp. 303–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Bishayee, A. Waghray, M. A. Patel, and M. Chatterjee, “Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence,” Cancer Letters, vol. 294, no. 1, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus